Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Citation data

CrossRef

Works that cite this article, indexed by Crossref.

29 resultsUpdated August 09, 2026

← Back to article

The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma

Journal of Oncology 2021 (2021)

Hao Zhang; Renzheng Liu; Lin Sun; Weidong Guo; Xiao Hu; Alessandro Granito

A New CYP2E1 Inhibitor, 12‐Imidazolyl‐1‐dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology 2021(1) (2021)

Torsten Diesinger; Alfred Lautwein; Sebastian Bergler; Dominik Buckert; Christian Renz; Radovan Dvorsky; Vyacheslav Buko; Siarhei Kirko; Edith Schneider; Florian Kuchenbauer; Mukesh Kumar; Cagatay Günes; Felicitas Genze; Berthold Büchele; Thomas Simmet; Martin Haslbeck; Kai Masur; Thomas Barth; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner; Alessandro Granito

Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer

Journal of Chemotherapy 37(5) (2025)

Feng Ju; Kaixia Chen; Dengyang Yin

Cold-water extracts of Grifola frondosa and its purified active fraction inhibit hepatocellular carcinoma in vitro and in vivo

Experimental Biology and Medicine 241(13) (2016)

Chia-Hung Lin; Ching-Yao Chang; Kuan-Rong Lee; Hui-Ju Lin; Wu-Chou Lin; Ter-Hsin Chen; Lei Wan

Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Oncology 2021 (2021)

Dongyu Wu; Guangcong Zhang; Jiamei Ma; Hongfen Wu; Ju Xiong; Xiaoxi Huang; Yuanyuan Tian; Taozhi Deng; Xiangyang Han; Xiaoning Sun; Tian Xiang; Xiangnan Yu; Xuemei Jiang; Alessandro Granito

Immunotherapy in hepatocellular carcinoma

Annals of Hepatology 18(2) (2019)

Luigi Buonaguro; Angela Mauriello; Beatrice Cavalluzzo; Annacarmen Petrizzo; Maria Tagliamonte

An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review

Mini-Reviews in Medicinal Chemistry 22(6) (2022)

Amit Kumar; Ankit Siwach; Prabhakar Verma

Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure

Digestive and Liver Disease 47(6) (2015)

Alessandro Granito; Sara Marinelli; Eleonora Terzi; Fabio Piscaglia; Matteo Renzulli; Laura Venerandi; Francesca Benevento; Luigi Bolondi

Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation

Technology in Cancer Research & Treatment 22 (2023)

Renguo Guan; Jie Mei; Rongping Guo

RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma

Clinical and Experimental Medicine 22(2) (2022)

Yue Li; Xiaoqin He; Xiaoyu Zhang; Yangtao Xu; Wenliang Chen; Xin Liu; Ximing Xu

Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience

SpringerPlus 5(1) (2016)

Amr Shaaban Hanafy

Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine

European Journal of Surgical Oncology 47(8) (2021)

Zainul Abedin Kapacee; Mairéad G. McNamara; Nicola de Liguori Carino; Angela Lamarca; Juan W. Valle; Richard A. Hubner

CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma

Frontiers in Oncology 11 (2021)

Bowen Li; Shibo Wei; Liang Yang; Xueqiang Peng; Yingbo Ma; Bo Wu; Qing Fan; Shuo Yang; Xinyu Li; Hongyuan Jin; Shilei Tang; Mingyao Huang; Hangyu Li; Jingang Liu

Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma

Frontiers in Oncology 11 (2021)

Tin-Yun Tang; Katherine Daunov; Richard T. Lee

Potentiating cancer vaccine efficacy in liver cancer

OncoImmunology 7(10) (2018)

Maria Tagliamonte; Annacarmen Petrizzo; Angela Mauriello; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma

Science Progress 104(3) (2021)

Jihan Wang; Yangyang Wang; Jing Xu; Qiying Song; Jingbo Shangguan; Mengju Xue; Hanghui Wang; Jingyi Gan; Wenjie Gao

Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation

Journal of Cancer Research and Clinical Oncology 144(2) (2018)

Franco Trevisani; Giovanni Brandi; Francesca Garuti; Maria Aurelia Barbera; Raffaella Tortora; Andrea Casadei Gardini; Alessandro Granito; Francesco Tovoli; Stefania De Lorenzo; Andrea Lorenzo Inghilesi; Francesco Giuseppe Foschi; Mauro Bernardi; Fabio Marra; Rodolfo Sacco; Giovan Giuseppe Di Costanzo

Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma

Canadian Journal of Gastroenterology and Hepatology 2021(1) (2021)

Wei Sun; Yongchao Zhang; Bozhi Liu; Youjia Duan; Wei Li; Jinglong Chen; Alessandro Granito

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives

Hepatic Oncology 5(1) (2018)

Francesco Tovoli; Giulia Negrini; Francesca Benevento; Chiara Faggiano; Elisabetta Goio; Alessandro Granito

Untitled

Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma

International Journal of Molecular Sciences 22(6) (2021)

Jianrong Zheng; Liao Zeng; Mingqing Tang; Hongjun Lin; Chao Pi; Ruian Xu; Xiuling Cui

Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology

Clinical Colorectal Cancer 20(3) (2021)

Linda Beenet

Distribution of Breast Density in Iranian Women and its Association with Breast Cancer Risk Factors

Iranian Red Crescent Medical Journal 15(12) (2013)

Nasrin Ahmadinejad; Sajjadeh Movahedinia; Samaneh Movahedinia; Kourosh Holakouie Naieni; Saharnaz Nejat

A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma

Frontiers in Immunology 13 (2022)

Guanghao Li; Yongheng Liu; Yanting Zhang; Yao Xu; Jin Zhang; Xianfu Wei; Zhongmin Zhang; Chao Zhang; Jinyan Feng; Qiang Li; Guowen Wang

Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells

Oncology Letters (2019)

Changjiang Lei; Defa Ren; Meixia Fu; Chuantao Sun; Hong Ren; Qingyun Pan; Yuan Li